Table 1.
Patient demographic and outcome data
| Patient Characteristics | Result |
|---|---|
| Total Number of Patients | 20 |
| Gender (M/F) | 10M/10F |
| Median Age (months, IQR) | 31 (4.5, 152) |
| Weight (kg) | 22.2 ± 19.8 |
| Ethnicity | |
| Caucasian | 6 (30%) |
| Hispanic | 9 (45%) |
| African American | 5 (25%) |
| Diagnosis | |
| ASD | 3 (15%) |
| VSD | 2 (10%) |
| CAVC | 2 (10%) |
| Common atrium | 1 (5%) |
| TOF | 6 (30%) |
| Subaortic membrane | 2 (10%) |
| Tricuspid atresia | 2 (10%) |
| DORV | 2 (10%) |
| STAT | |
| Category 1 | 8 (40%) |
| Category 2 | 11 (55%) |
| Category 4 | 1 (5%) |
| Median CPB Time (min, IQR) | 68 (54, 101) |
| Median CCT Time (min, IQR) | 33 (23, 38) |
| Median 24-hour fluid balance (mL/kg, IQR) | +27 (12, 63) |
| Median duration of respiratory support (hours, IQR) | 5 (2, 17) |
| CPB Prime Protocol Standard | |
| >10 kg: Heparin, methylprednisolone, and aminocaproic acid | 11 |
| <10 kg: Heparin, methylprednisolone, and aminocaproic acid, red blood cells, fresh frozen plasma | 9 |
Abbreviations: ASD; atrial septal defect, CAVC; common atrioventricular canal, DOR; double outlet right ventricle, STAT; Society of Thoracic Surgery Congenital Heart Surgery Mortality Score, TOF; tetralogy of Fallot, VSD; ventricular septal defect, M; male, F; female, CPB; cardiopulmonary bypass time, CCT; aortic cross-clamp time, SD; standard deviation, IQR; interquartile range, CPB; Cardiopulmonary Bypass